CRVO · CervoMed Inc.
AI read · Good for CRVO
The AI's read
The marker change gives CervoMed an encouraging early sign that its drug may affect nerve-cell damage. Most patients tolerated treatment. One person stopped after liver enzymes rose, but the levels returned to normal. Another marker stayed steady, and the study has not yet shown better speech or daily function. The rest of the study will test whether these early lab changes lead to patient benefits.